Description
Anti-retroviral drugs and AIDS prevention programs have helped to decrease the rate of new HIV-1 infections in some communities, however, a prophylactic vaccine is still needed to control the epidemic world-wide. Despite over two decades of research, a vaccine against HIV-1 remains elusive, although recent clinical trials have shown promising results.
Copyright Statement
Download count: 0
Details
Contributors
- Kessans, Sarah (Author)
- Mor, Tsafrir S (Thesis advisor)
- Matoba, Nobuyuki (Committee member)
- Mason, Hugh (Committee member)
- Hogue, Brenda (Committee member)
- Fromme, Petra (Committee member)
- Arizona State University (Publisher)
Date Created
The date the item was original created (prior to any relationship with the ASU Digital Repositories.)
2011
Subjects
Resource Type
Collections this item is in
Note
- Vita
- Partial requirement for: Ph.D., Arizona State University, 2011Note typethesis
- Includes bibliographical references (p. 118-149)Note typebibliography
- Field of study: Molecular and cellular biology
Citation and reuse
Statement of Responsibility
by Sarah Kessans